Neoadjuvant and adjuvant therapy in triple negative breast cancer
25 Jan 2018
Neoadjuvant and adjuvant therapy in triple negative breast cancer
The DESKTOPIII trial in platinum-sensitive ovarian cancer
Endocervical adenocarcinoma: The Silva system and a new classification proposal.
The patient perspective for HARMONY
Bridging radiotherapy gaps in Africa
Focus on screening, not biomarkers
Inequalities in immuno-oncology access across Europe
Measuring innovation and value in healthcare systems
Could personalised medicine increase inequality to medicine access?
The economics of personalised medicine in low and middle income countries
Creating a culture of shared data
Accelerating research to the bedside